International Conference on “Neurotrophic Factors and Neurodegenerative Disorders; Current Advances and Future Perspectives”
Virtual │ August 27th-29th 2021
Heraklion, Crete, Greece
We kindly invite you to the conference entitled “Neurotrophic Factors and Neurodegenerative Disorders; Current Advances and Future Perspectives” that will be organised in the context of the “EuroNeurotrophin” project by FORTH, in Crete, on August 27th-29th 2021.
The Conference will be delivered as a virtual event and registration is free of charge.
Neurodegenerative diseases (ND), like Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis and motor neuron disease, are on the rise worldwide. Alzheimer’s disease alone affects 36 million people in the world and 7 million in Europe. The economic burden for ND exceeds 724 billion € and it will become a trillion euros by 2019. Currently, there is no cure for any ND and most of the available drugs fail to tackle ND pathogenesis.
Neurotrophins are a family of closely related secreted proteins that have been shown to control a number of aspects of survival, development and function of neurons both in the central and the peripheral nervous systems.
Preclinical studies point to the therapeutic potential of neurotrophins in preventing or slowing the progression of ND. Thus, neurotrophins have been proposed as therapeutic agents for neurodegenerative diseases.
However, the poor pharmacokinetic properties of neurotrophins, mainly because of their sensitivity to proteolysis, restricted penetration of the blood–brain barrier, and limited ability to diffuse in tissues, render their use as drugs prohibitive.
The EuroNeurotrophin project aims to address the major limitations of neurotrophins by developing novel small molecule, neurotrophin mimetics with favourable profiles of stability, tissue penetration and targeted biological actions.
The EuroNeurotrophin project is the first European consortium to study small molecule neurotrophin mimetics (synthetic or natural) in depth, use them as molecular probes to interrogate neurotrophins, and emphasise their clinical translation.
We look forward to seeing you online in August!
Registration is now closed
Deadline Registration: 25 August 2021
Prof. Ioannis Charalampopoulos
Foundation for Research and Technology Hellas, Greece
Institute of Molecular Biology and Biotechnology
Dr. Theodora Calogeropoulou
Chairman of the Scientific Council of ICB
Institute of Chemical Biology
National Hellenic Research Foundation